Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Q2 2025 Earnings Call Transcript February 28, 2025 Silviu Itescu: Good morning, everybody. I’m Silviu Itescu. I’m the Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback